First Trust Advisors
AKCA

First Trust Advisors’s Akcea Therapeutics Inc AKCA Stock Holding History

First Trust Advisors’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-74,954
Closed -$2.12M – 2553
2019
Q1 		$2.12M Buy
74,954
+460
+0.6% +$13.4K ﹤0.01% 1523
2018
Q4 		$2.25M Buy
+74,494
New +$2.09M 0.01% 1406

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

First Trust Advisors's AKCA Position: Q2 2019 in Review

First Trust Advisors sold out of Akcea Therapeutics Inc (AKCA) in Q2 2019, closing a stake of 74,954 shares — an estimated $2.12M sold.

First Trust Advisors first reported a position in AKCA in Q4 2018 and held it in 2 quarters. The position peaked at $2.25M in Q4 2018. 68 funds tracked by Wall St. Rank hold AKCA as of Q2 2019.

  • First Trust Advisors reported no remaining Akcea Therapeutics Inc position as of Q2 2019 after selling out during the quarter.
  • First Trust Advisors sold 74,954 Akcea Therapeutics Inc shares in Q2 2019, an estimated $2.12M.
  • First Trust Advisors first reported a position in Akcea Therapeutics Inc in Q4 2018 and held it in 2 quarters.
  • First Trust Advisors's Akcea Therapeutics Inc position peaked at $2.25M in Q4 2018.
  • 68 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q2 2019.

Based on First Trust Advisors's 13F filing for Q2 2019, filed 30 Jul 2019.